Paragraph 1
Paragraph 2
- Who can participate: Individuals aged 18 to 65 years with a diagnosis of hypertension are eligible to participate. Key eligibility factors include stable medication regimen for at least three months and no history of severe cardiovascular events.
- Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. They will be required to attend regular clinic visits for blood pressure monitoring and health assessments. Adherence to the medication regimen will be tracked throughout the study period.
- Study Timelines and Visits: Study Timeline. Num Visits.
How understandable was the trial content above?
Hard to understand
Easy to understand